Sneak peEk

Clinical development outsourcing is evolving

From increased adoption of FSP and hybrid models to new approaches in recruitment and global resourcing, sponsors are considering emerging delivery approaches and opportunities to improve flexibility, efficiency and delivery as they build their outsourcing strategies. 

• Adoption of FSP and hybrid models are accelerating. An increased number of survey participants reported their use of both outsourcing approaches for the majority of their clinical development outsourcing. 
• Outsourcing is expected across a broad range of activities, ranging from clinical laboratory and diagnostic services and patient recruitment to clinical trial management, biostatistics, real-world data and evidence and data management. 
• FSP strategies are becoming more global and flexible. Bespoke recruitment, established operations across global locations and follow-the-sun models allow sponsors to access talent, maintain continuity and reduce bottlenecks. 
• The right partnership is critical to execution. On-time delivery, deep expertise, collaborative implementation, tailored recruitment, global capabilities and support for expansion into non-footprint countries are important considerations when selecting an FSP partner. 

As FSP and hybrid outsourcing models play a larger role in clinical development, biopharma and biotech sponsors have an opportunity to rethink how they access expertise, deploy resources and support programs globally. Strategic collaboration, innovative FSP models and global capabilities allow organizations to build greater flexibility and keep clinical development program delivery on time and on budget.